Clinical Trial Update: Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Houyanqing Oral Liquid for prevention and treatment of radiation-induced oral mucositis in nasopharyngeal carcinoma patients; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma
• Oral Mucositis

Drugs mentioned

• Houyanqing Oral Liquid

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Cancinoma (NPC), Radiation-induced Oral Mucositis | Phase 3 | Status: RECRUITING